-+ 0.00%
-+ 0.00%
-+ 0.00%

J&J - FEWER THAN 1% DISCONTINUE RYBREVANT FASPRO PLUS LAZCLUZE DUE TO TREATMENT-RELATED EVENTS AT ONE YEAR

Reuters·09/15/2026 03:02:14

Please log in to view news